Convatec Group (CNVVY) Fair Value & Analysis
Healthcare · US · Market cap $5.3B
Convatec Group
CNVVY · US
Fair value as of: Jul 15, 2026
From 25 valuation models · updated 8 days ago
Share price +6.7% over the past month.
Price vs Fair Value (12 months)
12‑month range $10.43 – $13.74 · fair‑value band $4.53 – $9.87 · the $11.54 price screens above the $7.90 fair value. As of Jul 15, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Convatec Group (CNVVY) currently trades at $11.54, while our model-based Fair Value estimate is $7.90, implying the stock looks roughly 31.5% overvalued today. We read business quality at 58/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Convatec Group generated revenue of $2.4B at a net margin of 7.2%. Revenue grew 7.1% year over year. It earns a return on equity of 10.9%. Net debt stands at $1.4B. Fundamentals as of Jul 15, 2026
Our scenario range runs from $4.53 (bear case) to $9.87 (bull case); at $11.54, the current price sits above that range. The share trades about 29% below its 52-week high and 11% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -38% fair-value upside, at -32%, CNVVY screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 15, 2026. TTM = trailing twelve months.
About the company
Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Convatec Group reported revenue of $2.4B in FY2025 versus $2.0B in FY2021, a compound +4.7%/yr. Reported net income was $175M in FY2025, compounding +10.5%/yr from FY2021.
Is CNVVY fairly valued? → Check now
Recent news
- Convatec Group (LSE:CTEC) Stock Gets Fair Value Bump As Analysts Draw Mixed Targets
- Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions
- How The Convatec Group (LSE:CTEC) Investment Narrative Is Evolving With An Unchanged Fair Value
- Discover Burberry Group And 2 Additional UK Stocks That May Be Trading Below Their Estimated Value
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection, not financial advice.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | C$20.93 | C$9.25 | -56% |
| EssilorLuxottica Société anonyme ESLOF | $205.86 | $114.90 | -44% |
| Medline Inc MDLN | $36.54 | $30.66 | -16% |
| HOYA Corporation HOCPY | $162.33 | $101.00 | -38% |
| Becton, Dickinson and Company BDX | $149.56 | $117.04 | -22% |
| Alcon Inc ALC | $66.58 | $36.99 | -44% |
| ResMed Inc RMD | $193.57 | $187.89 | -3% |
| West Pharmaceutical Services, Inc WST | $314.50 | $120.69 | -62% |
| Terumo Corporation TRUMF | $14.62 | $12.65 | -13% |
| Straumann Holding SAUHY | $12.68 | $5.49 | -57% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Convatec Group (CNVVY) undervalued?
What is the fair value of CNVVY?
What is the quality score of CNVVY?
What is the revenue of Convatec Group (CNVVY)?
What is the net profit margin of CNVVY?
Does Convatec Group pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Convatec Group analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.